PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 108 filers reported holding PASSAGE BIO INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $79,389 | -30.1% | 82,895 | +0.7% | 0.00% | -100.0% |
| Q4 2022 | $113,600 | +3.3% | 82,319 | -6.3% | 0.00% | 0.0% |
| Q3 2022 | $110,000 | +15.8% | 87,832 | +117.8% | 0.00% | 0.0% |
| Q2 2022 | $95,000 | -34.0% | 40,321 | -12.9% | 0.00% | 0.0% |
| Q1 2022 | $144,000 | -2.7% | 46,303 | +98.6% | 0.00% | 0.0% |
| Q4 2021 | $148,000 | – | 23,313 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 2,497,922 | $63,872,000 | 14.76% |
| FRAZIER MANAGEMENT LLC | 5,009,219 | $128,086,000 | 9.86% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 602,248 | $15,399,000 | 7.53% |
| Vivo Capital, LLC | 1,487,038 | $38,024,000 | 1.70% |
| Boxer Capital, LLC | 1,928,315 | $49,307,000 | 1.58% |
| Orbimed Advisors | 6,962,899 | $178,041,000 | 1.56% |
| Logos Global Management LP | 344,438 | $8,807,000 | 0.76% |
| EMERALD ADVISERS, LLC | 340,698 | $8,712,000 | 0.29% |
| Ikarian Capital, LLC | 136,697 | $3,495,000 | 0.15% |
| Weiss Multi-Strategy Advisers LLC | 300,554 | $7,685,000 | 0.15% |